Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qylur Intelligent Systems is an artificial intelligence and IIoT company that develops automated screening and diagnostic solutions for large-scale venues and healthcare environments. The company's flagship product, the Qylatron Entry Experience Platform, utilizes multi-sensor fusion and machine learning to provide autonomous security and health screening. During the COVID-19 pandemic, Qylur expanded its focus to include rapid, non-invasive health diagnostics through its Qylur Health division. Their technology integrates advanced sensing with cloud-based AI to detect pathogens and security threats in real-time. The company aims to streamline public safety and health monitoring through intelligent automation. Qylur's solutions are designed to improve operational efficiency while enhancing the user experience at high-traffic entry points.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qylur Intelligent Systems.